5/9/2025

Kenvue Inc (KVUE) outlines its strategic focus on innovation and market expansion amid a challenging economic landscape, maintaining confidence in its growth outlook for 2025.

Source: Yahoo

5/8/2025

Editor’s Note: Self care segment revenue growth updated Consumer health company Kenvue Inc. (NYSE:KVUE) on Thursday reported first-quarter 2025 sales of $3.74 billion, beating the consensus of $3.68 billion. Sales decreased 3.9% year over year, reflecting a 1.2% organic sales decline and a 2.7% foreign currency headwind. The organic sales decline was driven by 0.3% unfavorable value realization, reflecting planned strategic price investments, and a 0.9% volume decline. Some of Kenvue's most icon

Source: Yahoo

5/8/2025

Mattel on Thursday named consumer health giant Kenvue's Paul Ruh as CFO, replacing Anthony DiSilvestro. Ruh was the finance chief of the Tylenol maker following its spinoff from drug and medical device maker Johnson & Johnson in 2023. He was replaced by Kellanova's Amit Banati as CFO earlier on Thursday.

Source: Yahoo

5/8/2025

Health Care Down on Cyclical Bias -- Health Care Roundup

Source: MarketWatch

5/8/2025

Kenvue (NYSE:KVUE) recently appointed Amit Banati as its new CFO, an executive change aligning with its strategy to augment shareholder value. Concurrently, the company raised its net sales guidance for 2025, expecting an increase of up to 3%, and reported first-quarter earnings with net income of $296 million. During the last quarter, Kenvue's share price moved up by 17%, a shift resonating with broader positive market trends, including a 7.7% market climb over the past year. These events,...

Source: Yahoo

5/8/2025

Kenvue Inc. stock rises Thursday, outperforms market

Source: MarketWatch

5/8/2025

Mattel Names Paul Ruh as Financial Chief, Succeeding DiSilvestro

Source: MarketWatch

5/8/2025

While the top- and bottom-line numbers for Kenvue (KVUE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Source: Yahoo

5/8/2025

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, while warning that foreign exchange would weigh on adjusted earnings.

Source: Yahoo

5/8/2025

Kenvue, Inc. (NYSE:KVUE) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSofya Tsinis - Head of Investor RelationsThibaut Mongon...

Source: SeekingAlpha

5/8/2025

Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates.

Source: Yahoo

5/8/2025

Kenvue (KVUE) delivered earnings and revenue surprises of 9.09% and 1.70%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/8/2025

As Kenvue’s CFO, Amit Banati is set to receive a $2.5 million one-time cash bonus, the company said.

Source: Yahoo

5/8/2025

SUMMIT, N.J-Kenvue Inc. , today announced the appointment of Amit Banati as the Company's Chief Financial Officer, effective May 12, 2025. He will be responsible for overseeing the Finance and...

Source: Finnhub

5/8/2025

Investing.com -- Kenvue Inc. reported second-quarter earnings that surpassed analyst estimates, while updating its full-year 2025 guidance to account for tariffs and currency headwinds.

Source: Yahoo

5/8/2025

Kenvue on Thursday forecastthat its annual profit would be flat year-over-year as theconsumer health firm anticipates a $150 million impact fromPresident Donald Trump's trade tariffs implemented on...

Source: Finnhub

5/8/2025

SKILLMAN, N.J. (AP) — Kenvue Inc. KVUE) on Thursday reported first-quarter profit of $322 million. On a per-share basis, the Skillman, New Jersey-based company said it had net income of 17 cents.

Source: Yahoo

5/8/2025

SUMMIT, N.J., May 08, 2025--Kenvue Inc. (NYSE: KVUE) today announced financial results for the first quarter ended March 30, 2025.

Source: Yahoo

5/8/2025

SUMMIT, N.J., May 08, 2025--Kenvue Inc. (NYSE: KVUE), today announced the appointment of Amit Banati as the Company’s Chief Financial Officer, effective May 12, 2025. He will be responsible for overseeing the Finance and Strategy functions, supporting initiatives aimed at accelerating profitable growth and delivering value to shareholders. Following a thorough and thoughtful search process, Mr. Banati will succeed Paul Ruh, who will remain with the Company for a brief period to help ensure a smo

Source: Yahoo

5/8/2025

The following slide deck was published by Kenvue Inc.

Source: SeekingAlpha